drugset / Trial / NCT00003344

Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer

NCT00003344

Phase 1/2 Completed 49 enrolled Medical University of South Carolina
Treatment

Summary

RATIONALE: Radiation therapy uses high energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy plus irinotecan in treating patients with colon cancer that is recurrent or that cannot be removed surgically.

Timeline

Start
1998-08
Primary completion
2000-01
Completion
2000-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule Intravenous

Indications